Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Kaffe Bueno Aps has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are being reviewed by 2 distinct examiners, showing a one-to-one ratio of pending actions to examiners. Furthermore, the portfolio is active across 2 distinct art units, which indicates that each pending action is likely situated in a different technical niche.
SHELLHAMMER, JAMES PAUL is identified as the busiest examiner, with 1 busiest examiner pending office action. Given that there are 2 pending office actions in total, this examiner is responsible for half of the current pending workload. The other 1 pending office action is managed by the second of the 2 distinct examiners.
The distribution across 2 distinct art units means that practitioners must navigate the procedural nuances of two different sections of the office. With 2 distinct examiners involved, the company faces two independent sets of examiner preferences. Monitoring the 1 busiest examiner pending office action assigned to SHELLHAMMER, JAMES PAUL is essential for managing the current prosecution pipeline effectively.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHELLHAMMER, JAMES PAUL | 1 | 10.0% | +18.8% |
| VIGIL, TORIANA NICHOLE | 1 | 53.1% | +24.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18572569 | COFFEE MELANOIDIN NANOPARTICLES AND NANOFIBERS | SHELLHAMMER, JAMES PAUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17757741 | COSMETIC COMPOSITIONS COMPRISING MELANOIDINS | VIGIL, TORIANA NICHOLE | 35d overdue |
| 18572569 | COFFEE MELANOIDIN NANOPARTICLES AND NANOFIBERS | SHELLHAMMER, JAMES PAUL | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18572569 | COFFEE MELANOIDIN NANOPARTICLES AND NANOFIBERS | SHELLHAMMER, JAMES PAUL | 1617 | §103 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 17757741 | COSMETIC COMPOSITIONS COMPRISING MELANOIDINS | VIGIL, TORIANA NICHOLE | 1612 | §103 | Final Rejection | 35d overdue | Pending | Jun 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial